Effects of alendronate on the removal torque of implants in rats with induced osteoporosis

International Journal of Oral and Maxillofacial Implants

Volumn 18, Issue 2, 2003, Pages 218-223

  Narai, Satoru ^a   Nagahata, Shunichiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Alendronate; Dental implants; Osteoporosis; Ovariectomy; Rat; Removal torque; Titanium

Indexed keywords

ALENDRONIC ACID; TITANIUM; ALKALINE PHOSPHATASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMUR; METAPHYSIS; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; RAT; TOOTH IMPLANTATION; TORQUE; ANIMAL; BLOOD; BODY WEIGHT; BONE REGENERATION; DEVICE REMOVAL; IMPLANT; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALENDRONATE; ALKALINE PHOSPHATASE; ANIMALS; BODY WEIGHT; DENTAL IMPLANTS; DEVICE REMOVAL; FEMALE; FEMUR; IMPLANTS, EXPERIMENTAL; OSSEOINTEGRATION; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TITANIUM; TORQUE;

EID: 0038072942     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bryant SR, Zarb GA. Osseointegration of oral implants in older and younger adults. Int J Oral Maxillofac Implants 1998;13:492-499.
2. Zarb GA, Schmitt A. Implant therapy alternatives for geriatric edentulous patients. Gerodontology 1993;10:28-32.
3. Kondell PA, Nordenram A, Landt H. Titanium implants in the treatment of edentulousness: Influence of patient's age on prognosis. Gerodontics 1988;4:280-284.
4. Bass SL, Triplett RG. The effects of preoperative resorption and jaw anatomy on implant success. A report of 303 cases. Clin Oral Implants Res 1991;2:193-198.
5. Jemt T. Implant treatment in elderly patients. Int J Prosthodont 1993;6:456-461.
6. Ochi S, Morris HF, Winkler S. Patient demographics and implant survival at uncovering. Dental Implant Clinical Research Group: Interim report no. 6. Implant Dent 1994;3:247-251.
7. Pan J, Zhang F, Qi D. The effects of experimental osteoporosis on bone tissues around hydroxyapatite. Zhonghua Kou Qiang Yi Xue Za Zhi 2000;35:362-364.
8. Delmas PD, Hardy P, Garnero P, Dain M. Monitoring individual response to hormone replacement therapy with bone markers. Bone 2000;26:553-560.
9. Lane JM, Russell L, Khan SN. Osteoporosis. Clin Orthop 2000;372:139-150.
10. Millet PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in rat model. J Bone Joint Surg [Am] 2002;84:236-249.
11. Bikle DD, Morey ER, Doty SB. Currier PA, Tanner SJ, Halloran BP. Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage. J Bone Miner Res 1994;9:1774-1787.
12. Sahn M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993;91:2004-2011.
13. Meraw SJ, Reeve CM, Wollan PC. Use of alendronate in peri-implant defect regeneration. J Periodontol 1999;70:151-158.
14. Denissen H, van Beek E, van den Bos T, de Blieck J, Klein C, van den Hooff A. Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro. J Bone Miner Res 1997;12(2):290-297.
15. Nakajima D, Kim CS, Oh TW, et al. Suppressive effects of genistein dosage and resistance exercise on bone loss in ovariectomized rats. J Physiol Anthropol Appl Human Sci 2001;20(5):285-291.
16. Mosekilde L, Sogaard CH, McOsker JE, Wronski TJ. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate) - Assessed in sexually mature, ovariectomized rats. Bone 1994;15(4):401-408.
17. Struys A, Snelder AA, Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995;99:235-242.
18. Kodama Y, Nakayama K, Fuse H, et al. Inhibition of bone resorption by pamidoronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats. J Bone Miner Res 1997;12:1058-1067.
19. Thadani PJ, Waxman B, Sladek E, Barmada R, Gonzalez MH. Inhibition of particulate debris-induced osteolysis by alendronate in rat model. Orthopedics 2002;25(19):59-63.
20. Mac Willam KM, Moody AH, Silk J. Variation in alkaline phosphatase result using the method of Bessery, Lowry and Brock. Clin Chim Acta 1967;17:514-515.
21. Fujimoto T, Niimi A, Sawai T, Ueda M. Effects of steroid-induced osteoporosis on osseointegration of titanium implants. Int J Oral Maxillofac Implants 1998;13:183-189.
22. Nevins ML, Karimbux NY, Weber HP, Giannobile WV, Fiorellini JP. Wound healing around endosseous implants in experimental diabetes. Int J Oral Maxillofac Implants 1998;13:620-629.
23. Chappard D, Aguado E, Hure G, Grizon F, Basle MF. The early remodeling phases around titanium implants: A histomorphometric assessment of bone quality in a 3- and 6-month study in sheep. Int J Oral Maxillofac Implants 1999;14:189-196.
24. Johansson CB, Han CH, Wennerberg A, Albrektsson T. A quantitative comparison of machined commercially pure titanium and titanium-aluminum-vanadium implants in rabbit bone. Int J Oral Maxillofac Implants 1998;13:315-321.
25. Fujimoto T, Niimi A, Nakai H, Ueda M. Osseointegrated implants in a patient with osteoporosis: A case report. Int J Oral Maxillofac Implants 1996;11:539-542.
26. Tamura Y, Miyakoshi N, Itoi E, et al. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats. J Bone Miner Res 2001;16:541-549.
27. Nishizawa Y, Nakamura T, Ohata H, et al. Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001). J Bone Miner Metab 2001;19:338-344.
28. Garnero P, Darte C, Delmas PD. A model to monitor the efficacy of alendronate treatment in woman with osteoporosis using a biochemical marker of bone turnover. Bone 1999;24:603-609.
29. Braga de Castro Maschado A, Hannon R, Eastell R. Monitoring alendronate therapy for osteoporosis. J Bone Miner Res 1999;14:602-608.
30. Giavaresi G, Fini M, Gnudi S, et al. Comparison of calcitonin, alendronate and flurophosphate effects on ovariectomized rat bone. Biomed Pharmacother 2001;55:397-403.